hands_lines2

News & Events

Care. Commitment. Compassion.

News

One-World Inc. Celebrates 20 Years

One World is proud to celebrate 20 years of connecting the world of medicine with the world of need. As the global arm of specialty pharma, One-World evolved out of brokering pharmaceutical tenders in the 1990’s during the Iraqi Oil-for-Food/Medicine program through the U.S. State Department.

In 2001 the company was founded as a U.S. licensed Pharmaceutical Wholesaler and Exporter of Specialty Pharmaceuticals, Orphan Drugs and Clinical Trial Supplies and since then has operated in over 100 countries and provided treatments for 1,000’s of patients.

“We are so proud of the difference we have made these last 20 years.” said Tony Harper, Founder and CEO of One World. “Helping save lives and improve the quality of life of so many patients throughout the world is not only our mission, but also our passion. No one should ever suffer due to lack of access to much-needed medications. Today we celebrate 20 years of service to our global community and hope that in the next 20 years, our footprint will expand to reach more patients and additional underserved markets”

Upcoming Events

Korea Pharm & Bio

April 18th to 19th 2023

Looking forward to seeing you in Korea and discovering how we can be of service!

Meet us at Korea Pharm & Bio 2023, April 18– 19, 2023 in Seoul.

ExpoPharm

September 27th to 30th in Dusseldorf, Germany

How can our services benefit your business? We will be available for face-to-face discussions at our ExpoPharm booth.

Meet us at ExpoPharm September 27– 30, 2023 in Dusseldorf.

One-World works strictly with medical professionals, healthcare facilities, and humanitarian organizations licensed by the appropriate governing bodies. One-World does not do business with or have any association with Internet pharmacies. All vendors and customers are thoroughly vetted and required to provide copies of current licenses. One-World reserves the right to deny service to entities providing insufficient documentation or disputable results from credentials verification.